UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
News
San Diego Supercomputer Center’s Expanse Provides a Sneak Peek of the Extended Solar Corona
On Saturday, Dec. 4, a total eclipse of the sun will occur at 07:33 (Universal Time) over Antarctica and parts of the South Pacific near the southern tip of Chile. The solar corona – visible to the naked eye onl… […]
News
Novel Autism Mouse Model Based on an Epigenetic Gene Developed
Translational Psychiatry, researchers at University of California San Diego School of Medicine describe how, in a novel mouse model, epigenetic regulation negatively impacts a downstream gene specifically involve… […]
